• Comparing Quality of Life of General Population and Orthopedic Patients in Slovenia

    Sep 1, 2020, 00:00

  • PCN32 Cost Analysis of Chronic Myeloid Leukemia Patients Using Tyrosine Kinase Inhibitor in Vietnam

    Sep 1, 2020, 00:00

  • PRO18 Incidence, Mortality, Hospitalizations, and Expenditures for Pemphigus in Taiwan

    Sep 1, 2020, 00:00

  • PMH15 Children with Deficit in Executive Abilities Have a Risk for Emerging Weakness in Grammar Understanding

    Sep 1, 2020, 00:00

  • PAM3 Cost-Effectiveness of Kinesiology Taping for Patients with Mild to Moderate Ankle Sprain

    Sep 1, 2020, 00:00

  • PMD4 Analysis of Costs, Length of Hospital STAY (LOS), Readmission and Quality of Life in Patients Undergoing Primary TOTAL Knee Arthroplasty (TKA) from China ATTUNE® Study

    Sep 1, 2020, 00:00

  • PCN21 Disease Burden of Multiple Myeloma UNDER the Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PND7 Cost-Effectiveness of Cladribine Tablets in the Treatment of Relapsing-Remitting Multiple Sclerosis with High Disease Activity in Kazakhstan

    Sep 1, 2020, 00:00

  • PUK9 Adherence to Drug Therapy in Chronic Kidney Disease: A Systematic Review

    Sep 1, 2020, 00:00

  • PND24 Target Identification and Drug Repurposing for Parkinson's Disease: A NOVEL Integrative Computational Approach

    Sep 1, 2020, 00:00

  • PMH3 Desogestrel: Does IT Cause Severe Psychiatric Disorders, a Retrospective Analysis of FDA Adverse Event Reporting System and Eudravigilance

    Sep 1, 2020, 00:00

  • PCN43 Disease Burden of NON-SMALL CELL Cancer UNDER Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PMD9 Cost-Minimization Analysis of Robotic-Assisted Surgery for Gastric Cancer Patients in JAPAN

    Sep 1, 2020, 00:00

  • PMD2 The Relationship between Sedatives and Risk of Ventilator-Associated Events

    Sep 1, 2020, 00:00

  • PIH7 Cost of Illness of Inpatient Pediatric Pneumonia Patients Hospitalized in Yogyakarta Indonesia

    Sep 1, 2020, 00:00

  • PMS2 Disease Burden of Subsequent Fracture in Osteoporosis Patients in South Korea

    Sep 1, 2020, 00:00

  • PMH2 The IMPACT of Major Depression on Productivity in South Korea

    Sep 1, 2020, 00:00

  • PNS48 The Analysis of Sources of Utility Values USED in Cost-Utility Analyses in China

    Sep 1, 2020, 00:00

  • PNS46 Exploration of the Weight-Loss Management Service at Community Pharmacy in Malaysia

    Sep 1, 2020, 00:00

  • PCN88 HTA Evaluations of Oncology Drugs in APAC - Comparison of Trends and Drivers of Success in 5 Countries

    Sep 1, 2020, 00:00

  • PBI6 Research on CAR-T’S Market Access and Reimbursement Strategy in China

    Sep 1, 2020, 00:00

  • PIN36 Comparison of Vaccine Market Access Pathways in European and Asian Countries

    Sep 1, 2020, 00:00

  • PNS59 Reliability and Validity of the SF-12V2 Health-Related Quality of Life Survey and Disutilities Associated with Relevant Conditions in the U.S. Older Adult Population

    Sep 1, 2020, 00:00

  • PUK4 Cost-Effectiveness of Robotic-Assisted Partial Nephrectomy

    Sep 1, 2020, 00:00

  • PCN100 The Economic Burden of Gastric Cancer Mortality in Brazil/LATAM

    Sep 1, 2020, 00:00

  • PIH2 Does Fertility Treatment Provide Good VALUE for Money? a Cost-Benefit Analysis

    Sep 1, 2020, 00:00

  • PDG9 Cost Effectiveness Analysis of Blonanserin Versus Olanzapine As First-LINE Treatment for Patients with Schizophrenia in China

    Sep 1, 2020, 00:00

  • PIH14 Perception of Seriousness, Knowledge, and Willingness to Pay for Cervical Cancer Screening Among Women in Yogyakarta Province, Indonesia

    Sep 1, 2020, 00:00

  • PIN42 Current Trends in Covid-19 Testing Rates and Unmet NEEDS

    Sep 1, 2020, 00:00

  • PSU3 Clinical Outcomes and Economics Associated with Surgical Aortic Valve Replacement in Taiwan

    Sep 1, 2020, 00:00

  • Did You Get What You Wanted? Patient Satisfaction and Congruence Between Preferred and Perceived Roles in Medical Decision Making in a Hungarian National Survey

    Sep 1, 2020, 00:00

  • PCN101 Healthcare Resource Utilization, Costs, and Clinical Outcomes in Patients with Triple-Negative Breast Cancer in Northern Thailand: A Real World Evidence Using Electronic Health Records

    Sep 1, 2020, 00:00

  • PIN27 Projecting the Burden of Multidrug-Resistant Acinetobacter Baumannii Among Hospital-Associated Infections in China

    Sep 1, 2020, 00:00

  • PMS7 Osteoporosis Diagnosis and Treatment Among Women in China: A Simulation Projection Model of Clinical and Economic Benefits through 2040

    Sep 1, 2020, 00:00

  • PRS21 The Complexity and Medical Resources for COPD Patients in China

    Sep 1, 2020, 00:00

  • PMD14 Economic Analysis to Evaluate IMPACT of Prostheses Choice in Primary TOTAL Knee Arthroplasty

    Sep 1, 2020, 00:00

  • PCN84 Comparison of Treatment Among Peripheral T-CELL Lymphoma and Cutaneous T-CELL Lymphoma in China and United States: Results of Primary Market Research Survey of Oncologists

    Sep 1, 2020, 00:00

  • PRO17 Healthcare Resource Utilization (HCRU) in Patients with Palmoplantar Pustulosis (PPP) in JAPAN: A Claims Database Study

    Sep 1, 2020, 00:00

  • PDG3 Comparison of Pharmacoeconomic Evaluation Guidelines in Korea, JAPAN and China

    Sep 1, 2020, 00:00

  • PUK5 Remaining Waitlisted for a Superior Quality Kidney; An Economic Evaluation of Contemporary Transplant Practice

    Sep 1, 2020, 00:00

  • PDG4 Cost-Utilities Analysis of First LINE Treatments on Advanced STAGE EGFR Positive in NON-SMALL CELL LUNG Cancer Patients in Taiwan

    Sep 1, 2020, 00:00

  • PCN91 Penetration of Artificial Intelligence (AI) and Machine Learning (ML) in the Randomized Controlled Setting of Oncology

    Sep 1, 2020, 00:00

  • PIN11 Budget IMPACT of the National AIDS PLAN Recommended Guidelines for Preferent NO Coformulated Initial Antiretroviral Therapy in Naïve HIV-Infected Adults in Mexico in 2020

    Sep 1, 2020, 00:00

  • PCN39 Cost-Effectiveness of Brentuximab Vedotin for Relapsed or Refractory Systemic Anaplastic Large-CELL Lymphoma in China

    Sep 1, 2020, 00:00

  • PCN83 Real-World Prescription Patterns of HER2+/HR- Metastatic Breast Cancer Patients after Ado-Trastuzumab Emtansine Approval: A Retrospective Cohort Study Using Electronic Health Record DATA with Cancer Registries

    Sep 1, 2020, 00:00

  • PIN13 Clinicoeconomic IMPACT of an Alcohol Based Hand RUB to Reduce Gram Negative MULTI Drug Resistant Bacteria: A Simulation Study in an Indian Healthcare Setting

    Sep 1, 2020, 00:00

  • PIH5 Clinical and Economic Evaluation of ORAL Versus Intravenous Ibuprofen Therapy in Preterm Infants with Patent Ductus Arteriosus in the Neonatal Intensive Care Unit in Qatar

    Sep 1, 2020, 00:00

  • PCN71 Comparing the International Price of Anticancer Drugs and Improving Their Accessibility in South Korea

    Sep 1, 2020, 00:00

  • PMH10 Depression Severity Is Associated with Physical PAIN Severity across Countries

    Sep 1, 2020, 00:00

  • PCN46 Disease Burden of Chronic Lymphocytic Leukemia/SMALL Lymphocytic Lymphomaunder Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PNS34 IMPACT of Drug Price Formation Mechanism on Medicine Availability: Evidence from China

    Sep 1, 2020, 00:00

  • PCN4 Aromatase Inhibitors and Bisphosphonate Use in Postmenopausal Women with Hormone-Receptor Positive Breast Cancer in Hong Kong

    Sep 1, 2020, 00:00

  • PCN33 Cost-Effectiveness of Molecular Screening to Identify Lynch Syndrome in Iranian Patients with Colorectal Cancer

    Sep 1, 2020, 00:00

  • PIN28 Prediction of the PEAK Dates of the Numbers of COVID19 Pandemic Patients

    Sep 1, 2020, 00:00

  • PND5 Cost-Effectiveness Analysis of Newborn Screening for Spinal Muscular Atrophy in the United States

    Sep 1, 2020, 00:00

  • PNS10 Economic Evaluation in the Philippines before the Era of Mandatory Health Technology Assessment: A Systematic Review

    Sep 1, 2020, 00:00

  • PNS40 The Implementation of Volume-Based Drug Procurement Policy in China

    Sep 1, 2020, 00:00

  • PNS69 Measuring and Valuing Patient Experience

    Sep 1, 2020, 00:00

  • PMU25 Measuring Medication Adheren Application of Group-Based Trajectory MODEL for Australians with Chronic Health Conditions Requiring Continuous Use of Medication

    Sep 1, 2020, 00:00

  • PNS24 Willingness-to-Pay Thresholds Applied for Health Economic Analyses in Oncology in China: A Targeted Literature Review

    Sep 1, 2020, 00:00

  • PRO8 Analysis of Health Authorities Collaboration for Orphan Drug Designation and Their IMPACT on the Growth of Orphan Drug Market

    Sep 1, 2020, 00:00

  • Barriers to Diabetes Adherence: Translation and Cultural Adaptation of the Instrument Into Arabic Context [Editor's Choice]

    Sep 1, 2020, 00:00

  • PIH15 NOVEL Target Identification and Drug Repurposing for Systemic Onset Juvenile Idiopathic Arthritis (SJIA): An Insilico Approach

    Sep 1, 2020, 00:00

  • PDG25 Drug Therapy Problem and Contributing Factors in Ethiopia: A Systematic Review and Meta-Analysis

    Sep 1, 2020, 00:00

  • Prioritization of Medicine Importation by the Private Sector in Sudan: Evidence from a Data Analysis, 2012-2015

    Sep 1, 2020, 00:00

  • PDG5 Cost- Effectiveness Analysis between Aprepitant and Fosaprepitant in the Prevention of Chemotherapy-Induced Nausea and Vomiting in China

    Sep 1, 2020, 00:00

  • PNS25 Applying Regulatory Science to Traditional Medicines for Improving Public Safety and Facilitating Innovation: Experiences in China

    Sep 1, 2020, 00:00

  • PBI3 The Economic Evaluation Of Clopidogrel In Antiplatelet Therapy Guided By CYP2C19 Gene Polymorphism In The Treatment Of Patients With Coronary Heart Disease

    Sep 1, 2020, 00:00

  • PSU12 Landscape Analysis of Analgesics Utilization during Perioperative Period in China

    Sep 1, 2020, 00:00

  • PIN3 Is Dolutegravir Cost Effective in Treating Patients Living with HIV?

    Sep 1, 2020, 00:00

  • PRS6 Economic Eligibility Assessment for Patient Assistance Program (PAP) Among Chronic Obstructive Pulmonary Disease (COPD) Patients in Urban China

    Sep 1, 2020, 00:00

  • PCN52 Disease Burden of Prostate Cancer UNDER Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PND21 BUDGET IMPACT OF ROTIGOTINE ON CHINESE NATIONAL MEDICAL FUND PAYMENT FOR PARKINSON'S DISEASE

    Sep 1, 2020, 00:00

  • PCN79 Willingness to Pay for Cancer Screening Testing in Malaysia

    Sep 1, 2020, 00:00

  • PCN54 Drug Selection for Formulary Inclusion: An Exploratory Case Study of Oncology Medicines in Jordan

    Sep 1, 2020, 00:00

  • PRO13 In-Silico Determination of Therapeutic Possibilities for Type-1 Gaucher Disease: A GENE Database Linked Analysis

    Sep 1, 2020, 00:00

  • PUK7 Budget Impact Of A New Mobile Application Reimbursement Strategy For Diabetic Patients In Andhra Pradesh (India)

    Sep 1, 2020, 00:00

  • PIN12 Health and Economic IMPACT of 15-Valent Pneumococcal Conjugate Vaccine (V114) Serotypes in Adults 70 YEARS and Older in Australia

    Sep 1, 2020, 00:00

  • PCV19 Economic Burden of Disease on Patients with ACUTE Myocardial Infarction Combining Dyslipidemia in China

    Sep 1, 2020, 00:00

  • PCN48 Cost-Effectiveness Analysis of Pertuzumab with Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Neoadjuvant Treatment of HER2-Positive EARLY or Locally Advanced Breast Cancer: Update Results after National ...

    Sep 1, 2020, 00:00

  • PND10 Assessing the Cost of Treatment for Myasthenia Gravis Crisis Patients in Australia

    Sep 1, 2020, 00:00

  • PAM6 Cost IMPACT Analysis for Coated VS NON-Coated CVC in China

    Sep 1, 2020, 00:00

  • PSU14 Patient-Related Risk Factors for Periprosthetic Joint Infection and Postoperative Mortality Following TOTAL Knee Arthroplasty, a Nationwide Population-Based Study

    Sep 1, 2020, 00:00

  • PIN29 Evaluation of Healthcare Workers' Knowledge, Attitude and Practices Related to Covid-19: A Multicenter CROSS-Sectional Study from Pakistan

    Sep 1, 2020, 00:00

  • PAM2 Cost-Effectiveness of Thread Embedding Therapyfor Patients with Chronic, Herniated Lumbar Disk

    Sep 1, 2020, 00:00

  • PCN98 Assessment of Quality of Life in Patients with Metastatic Breast Cancer and Its Pharmaceutical Management in Tertiary Care Hospital: A Prospective Observational Study

    Sep 1, 2020, 00:00

  • PDB7 Cost-Effectiveness Analysis of Once-Weekly Semaglutide As the Second-LINE Treatment for Type 2 Diabetes Mellitus Patients

    Sep 1, 2020, 00:00

  • PNS14 Investigation of Physicians’ Digital Activities on Mitigating the IMPACT of Covid-19 in China

    Sep 1, 2020, 00:00

  • PDB15 Cost-Effectiveness of Gliclazide MR-Based Intensive Glucose Control Versus Standard Glucose Control in Type 2 Diabetes Mellitus: Pharmacoeconomic Analysis in Thailand Based on the Advance Trial MODEL

    Sep 1, 2020, 00:00

  • PCV2 Volatile Anesthetics Versus TOTAL Intravenous Anesthesia in Patients Undergoing Coronary Artery Bypass Grafting: An Updated Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials

    Sep 1, 2020, 00:00

  • PMD10 Cost-Utility Analysis of Robotic-Assisted Surgery for Prostate Cancer Patients in JAPAN

    Sep 1, 2020, 00:00

  • PCN92 An Investigation of Estimation Efficiency of Area UNDER the Curve (AUC) Using Parametric Models

    Sep 1, 2020, 00:00

  • PCN3 Knowledge of Treatment Assignment and Clinician Adverse Event Reporting: An Evaluation in Multiple Myeloma

    Sep 1, 2020, 00:00

  • PNS60 Use of Artificial Intelligence with Distillersr Software in Selected Systematic Literature Reviews

    Sep 1, 2020, 00:00

  • PDB10 Cost-Effectiveness of Canagliflozin Versus Sitagliptin in Chinese Patients with Type 2 Diabetes on Background Metformin Monotherapy

    Sep 1, 2020, 00:00

  • PSY2 Evaluating Patient-Reported Outcomes and Work Productivity Among Patients with Psoriasis in Taiwan

    Sep 1, 2020, 00:00

  • PIH6 Economic Evaluation of the Automated Resuscitator Device for Asphyxiated Neonates in Tertiary LEVEL Healthcare Setting in India

    Sep 1, 2020, 00:00

  • PIN34 Effects of Meteorological Factors on the Daily Domestic New CASES of Coronavirus Disease (COVID-19) in Asian Countries: A MULTI-Country Generalized Additive Modeling Analysis

    Sep 1, 2020, 00:00

  • PCN37 Cost-Effectiveness Analysis of Pembrolizumab Versus Nivolumab As the First-LINE Treatment for Advanced and Metastatic NON-SMALL CELL LUNG Cancer in France

    Sep 1, 2020, 00:00

  • PNS23 Setting Health Priorities in Low-Income and Middle-Income Countries in the ASIA-Pacific Region: The Case of Papua New Guinea

    Sep 1, 2020, 00:00

  • PMD12 Key Considerations of VALUE Assessment Frameworks for Medical Devices and Diagnostics in ASIA Pacific

    Sep 1, 2020, 00:00

  • PCN44 Disease Burden of Follicular Lymphoma UNDER the Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PMS18 Factors Influencing Length of STAY (LOS) and Real-World Discharge Readiness (DR) for TOTAL Knee Arthroplasty in Australia

    Sep 1, 2020, 00:00

  • PGI8 Facility Size-Based Diagnostic Patterns of the Crohn's Disease-Associated Perianal Fistula Using an Employer-Based Health Insurance Claims Database in JAPAN

    Sep 1, 2020, 00:00

  • PUK2 Assessing Mortality Risk and Renal Outcomes in Chronic Kidney Disease Patients Treated with Sglt-2 Inhibitors or DPP-4 Inhibitors: A Real-World Study

    Sep 1, 2020, 00:00

  • PMU20 Is There an Implicit Willingness-to-Pay Threshold in Singapore?

    Sep 1, 2020, 00:00

  • PMU15 Utilization and Spending of Low-VALUE Healthcare UNDER a National Health Insurance Program: A Nationwide Population-Based Study

    Sep 1, 2020, 00:00

  • PNS15 Effects of Different Family Planning Policies on Cesarean Section Rates from 2009 to 2019: A Population-Based Registry in China

    Sep 1, 2020, 00:00

  • PNS36 Cost-Benefit Analysis of Dental Prevention Programs for Children in Taiwan

    Sep 1, 2020, 00:00

  • PCN29 Diagnosing and Classifying ACUTE Leukemia Patients through Immunophenotyping By FLOW Cytometry in Indonesia

    Sep 1, 2020, 00:00

  • PUK3 Cost Consequence Analysis of Remote Monitoring with the Homechoice Claria® with Sharesource® Platform for Automated Peritoneal Dialysis Patients in the Australian Setting

    Sep 1, 2020, 00:00

  • PCN104 Treatment Patterns and Health Resource Utilization in Patients with HR+/HER2- Locally Advanced or Metastatic Breast Cancer in Real World Setting in Taiwan

    Sep 1, 2020, 00:00

  • PND25 Identification of NOVEL Drug Targets and Exploring Drug Repurposing Avenues for Amyotrophic Lateral Sclerosis

    Sep 1, 2020, 00:00

  • PCN73 Is Time to Access Novel Cancer Therapies in Asia Accelerating? A Preliminary Investigation

    Sep 1, 2020, 00:00

  • PCN56 Addressing the Credibility GAP of Real-World Evidence Generation in Southeast ASIA: An Analysis of 200 Articles over 10 YEARS

    Sep 1, 2020, 00:00

  • PAM4 Cost-Effectiveness of Dangguixu-SAN for Patients with Mild to Moderate Ankle Sprain

    Sep 1, 2020, 00:00

  • PND3 Patient-Reported Outcomes Following Neuromanual Therapy For Carpal Tunnel Syndrome- Comparison Of Four Patient Healthcare Outcome Measures In A Randomized Clinical Trial

    Sep 1, 2020, 00:00

  • Editorial Board

    Sep 1, 2020, 00:00

  • PIN4 Associations between Thromboprophylaxis and Ventilator-Associated Events Among Patients Receiving Mechanically Ventilated

    Sep 1, 2020, 00:00

  • PCN28 Cost-Effectiveness Analysis of Avelumab for Treatment-Experienced and Treatment-Naïve Patients with Metastatic Merkel CELL Carcinoma in Taiwan

    Sep 1, 2020, 00:00

  • PNS54 Competencies Required in the Profile of the Health Professional for Management and Assistance in Telemedicine Programs: A Review of the Literature

    Sep 1, 2020, 00:00

  • PIN41 Economic Burden of 2009 Pandemic H1N1 Influenza in Mainland China: A Systematic Review and Modelling Study

    Sep 1, 2020, 00:00

  • PMS8 Estimating the Future Clinical and Economic Benefits of Improving Osteoporosis Diagnosis and Treatment Rates Among Women in South Korea: A Simulation Projection Model from 2020-2040

    Sep 1, 2020, 00:00

  • PGI6 DISEASE BURDEN OF MODERATE TO SEVERE CROHN'S DISEASE UNDER CURRENT TREATMENT PATTERN IN CHINA

    Sep 1, 2020, 00:00

  • PRS13 Market Access of Asthma and COPD Medications As a Tool to Increase Drugs Availability in Russian Federation

    Sep 1, 2020, 00:00

  • PDG22 Comparison of Healthcare Systems and Opportunities for Innovative Drugs across India, Vietnam, and Indonesia

    Sep 1, 2020, 00:00

  • PDG1 Prevalence and Determinants of Serious Spontaneously Reported Adverse Drug Events Among Three Outpatient Care Settings in Ghana: Findings and Implications

    Sep 1, 2020, 00:00

  • PNS9 The Potential IMPACT of External Reference Pricing Rules on Selected Drug Prices in China

    Sep 1, 2020, 00:00

  • PCN41 Cost-Effectiveness of Pembrolizumab in Combination with Chemotherapy in the 1ST LINE Treatment of Metastatic NSCLC in Taiwan

    Sep 1, 2020, 00:00

  • PCN55 A Systematic Review and Narrative Synthesis of Health Economic Evaluations of Hepatocellular Carcinoma (HCC) Screening Strategies

    Sep 1, 2020, 00:00

  • PNS5 Comparison of Instruments Valuing Health-Related Productivity Losses

    Sep 1, 2020, 00:00

  • PRS14 The IMPACT of Heart Failure on the Economic Burden of Various Phenotypes of Bronchial Obstructive Diseases

    Sep 1, 2020, 00:00

  • PCN70 Budget Savings from Patent Expiration of Cancer Drugs in South Korea

    Sep 1, 2020, 00:00

  • PMU17 Health Technology Assessment for Procedures: The Evaluation of Innovation in JAPAN

    Sep 1, 2020, 00:00

  • PCN75 Characterization of Oncology Managed Entry Agreements (MEA) in APAC and Assessment of Payer Considerations

    Sep 1, 2020, 00:00

  • PMU6 Evaluation of the Application of the Hospital Management Program for Prevention and Treatment of Venous Thrombosis Based on Information Technology

    Sep 1, 2020, 00:00

  • PND26 Biological Activity of Ascaridole through Interference of Binding Sites of Topoisomerase I, Topoisomerase II, Acetylcholinesterase, SOD and Catalase for the Treatment of Alzheimer's Disorders

    Sep 1, 2020, 00:00

  • PCN74 Analyze Oncology Drug Price Change in the Chinese Market through National Reimbursement Drug LIST Negotiation

    Sep 1, 2020, 00:00

  • PIN21 Cost-Effectiveness of Ceftazidime-Avibactam for Gram-Negative Infections with Limited Treatment Options in China

    Sep 1, 2020, 00:00

  • PMU18 Budget IMPACT Analysis of the Eluvia Drug-Eluting Stent for Peripheral Artery Disease in Korea

    Sep 1, 2020, 00:00

  • PAM5 Cost-Effectiveness Analysis of Lusutrombopag for the Treatment of Thrombocytopenia in Chronic LIVER Disease Patients PRIOR to an Elective Invasive Procedure in JAPAN

    Sep 1, 2020, 00:00

  • PNS30 IMPACT of Cigarette Tax on Youth Smoking in Taiwan

    Sep 1, 2020, 00:00

  • PCN42 A Real World Comparison of Utility Values Derived from a Discrete Choice Experiment Versus Patient Reported Outcomes in Clinical Trials

    Sep 1, 2020, 00:00

  • PGI1 Systematic Review and Network Meta-Analysis of Infliximab, Adalimumab, Golimumab, Vedolizumab, Andtofacitinib for Moderate-to-Severe Ulcerative Colitis in ANTI-TNF-ALPHA-Naive Patients

    Sep 1, 2020, 00:00

  • PDB3 SGLT2 Inhibitors and Risk of Diabetic Ketoacidosis in Patients with Type 2 Diabetes: Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Sep 1, 2020, 00:00

  • PMS16 Longitudinal Analyses of Health-Related Quality of Life and Daily Activities Function Among HIP Fracture Population: A Real-World Prospective Cohort Study

    Sep 1, 2020, 00:00

  • PIH16 Use of Tripod Checklist to Evaluate the Reporting Quality of Prognostic Prediction Models for Obstetric Care

    Sep 1, 2020, 00:00

  • PNS41 Preferences of Older Patients with Chronic Diseases for Medication Review Services in Shanxi, China: Results from a Discrete Choice Experiment

    Sep 1, 2020, 00:00

  • PMD5 Evaluation of Cost Analysis of the Midline Catheter Versus Peripherally Inserted Central Catheter in Korea in the Inpatient Setting

    Sep 1, 2020, 00:00

  • PDG27 The Complexity and Cost of Drug Regimens for Hypertensive Patients in China

    Sep 1, 2020, 00:00

  • PND27 Valuing Health States Using Discrete Choice Experiment: Case of Cerebral Palsy

    Sep 1, 2020, 00:00

  • Evaluation of Psychometric Quality of EQ-5D-5L Scale for Assessing Health-Related Quality of Life of Malaria Patients

    Sep 1, 2020, 00:00

  • PND9 Effects and Cost of Gastrodin Injection on Dizziness and Vertigo: A Propensity Score-Matched Cohort Study Based on Real-World DATA

    Sep 1, 2020, 00:00

  • PIN24 Disease Burden of Progressive Chronic Hepatitis C in China

    Sep 1, 2020, 00:00

  • PNS56 Effect of the Recall Period for Estimating Inpatient out-of-Pocket Expenditures: Validation Study in Vietnam

    Sep 1, 2020, 00:00

  • PMU26 The Health-Related Quality of Life in Different Disease Population Based on EQ-5D-5L: A Systematic Review

    Sep 1, 2020, 00:00

  • PRO12 Investigation of Consistency of Haemophilia a Care in JAPAN: A Claims-Based Cohort Study

    Sep 1, 2020, 00:00

  • The Coronavirus Disease 2019 (COVID-19) Pandemic in Africa: What Can We Expect? [Editor's Choice]

    Sep 1, 2020, 00:00

  • PNS67 The Humanistic Burden of Caregiving in China, Japan, and the US

    Sep 1, 2020, 00:00

  • PNS22 Hospital Ownership and National Essential Medicines Policy: A Comparative Study between the Public and Private Primary Health-Care Institutions in Nantong, China

    Sep 1, 2020, 00:00

  • PIN23 Systematic Review of Economic Evaluations of Pneumococcal Conjugate Vaccines in Mainland China

    Sep 1, 2020, 00:00

  • PCN50 Disease Burden of Chronic Myeloid Leukemia UNDER Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PCN62 Investigation of Diseases Incidence after Administration of Immune Check Inhibitors in LUNG Cancer Based on Claims DATA in JAPAN

    Sep 1, 2020, 00:00

  • PCN57 Frequency of Myalgia in Patients Receiving Platinum Chemotherapy

    Sep 1, 2020, 00:00

  • PRS12 Prospective Association between LUNG Function and the Incidence of Diabetes, Asthma, Myocardial Infarction, Hypertension and ALL-Cause Mortality: Competing Risks MODEL

    Sep 1, 2020, 00:00

  • PAM1 Efficacy and Safety of Prebiotics, Probiotics and Synbiotics for Treatment or Prevention of Asthma: A Systematic Review and Network Meta-Analysis

    Sep 1, 2020, 00:00

  • PNS29 IMPACT of Pharmacoeconomic Evaluation Guidelines: A Systematic Review of Reporting Quality of Pharmacoeconomic Evaluations for NON-SMALL CELL LUNG Cancer in China

    Sep 1, 2020, 00:00

  • PDG20 Availability and Affordability of Oncologic Immunotherapies across Multiple-Countries

    Sep 1, 2020, 00:00

  • PNS71 ACCESSING MULTIPLE PATIENT DATA SOURCES TO ENHANCE GENERATION OF REAL-WORLD EVIDENCE, OUTCOME RESEARCH AND NON-RESEARCH EVALUATIONS

    Sep 1, 2020, 00:00

  • PCN107 Real World Chart Review of Treatment Patterns and Health Resource Utilization in Patients with Hepatocellular Carcinoma (HCC) Following Failure of Sorafenib in Korea

    Sep 1, 2020, 00:00

  • PIN8 Analysis of Potential Cost-Savings after Introduction of 0.1% Polihexanide/Betaine Solution for Chronic Wounds in Reimbursement Healthcare System of Korea

    Sep 1, 2020, 00:00

  • PCN108 Economic Burden in Patients with Prostate Cancer: Using HIRA NPS-2016 Database

    Sep 1, 2020, 00:00

  • PCN65 Disease and Economic Burden of Cancer Associated Thrombosis Among SOLID Tumour Malignancy in Malaysia

    Sep 1, 2020, 00:00

  • PRS16 Development of an Accurate Operational Definition for Asthma Using Logistic Regression MODEL

    Sep 1, 2020, 00:00

  • PDB9 Budget IMPACT Analysis of Empagliflozin in Type-2 Diabetes Patients with High Cardiovascular Risk in South Korea Based on Empa-REG OUTCOME® Trial: HIRA(HEALTH INSURANCE REVIEW ASSESSMENT SERVICE)-NPS (NATIONAL PATIENTS SAMPLE) Databas ...

    Sep 1, 2020, 00:00

  • PCN40 Cost-Utility Analysis of Pembrolizumab Versus Platinum Based Chemotherapy As the First-LINE Treatment for Advanced and Metastatic NON-SMALL CELL LUNG Cancer (NSCLC) in UK

    Sep 1, 2020, 00:00

  • PIN17 A Systematic Literature Review of the Disease and Economic Burden of Multidrug Resistance Gram Negative Infections (MRGN) in JAPAN

    Sep 1, 2020, 00:00

  • PSU1 Real-World Cost-Effectiveness Analysis of Minimal Invasive PLATE Osteosynthesis (MIPO) Versus Conventional OPEN Reduction Internal Fixation of Proximal Humeral Fracture (PHF)

    Sep 1, 2020, 00:00

  • PMU14 China's 2019 National Reimbursement Drug LIST Update: Implications on Global and Local Manufacturer Strategy

    Sep 1, 2020, 00:00

  • PCN20 Comparison of Nab-paclitaxel PLUS Gemcitabine Versus FOLFIRINOX in First LINE Treatment of Metastatic Pancreatic Cancer in China: A Cost-Effectiveness Analysis

    Sep 1, 2020, 00:00

  • PIN26 Assessment Of Influence Of Education To Parents Towards Completion Of Vaccination : A Randomised Controlled Study

    Sep 1, 2020, 00:00

  • PSU9 The Cost Analysis of Patients Undergoing TOTAL Knee Arthroplasty in China

    Sep 1, 2020, 00:00

  • PCV23 Budget IMPACT Analysis of Sacubitril Valsartan for Heart Failure Treatment in Indonesia

    Sep 1, 2020, 00:00

  • PMU12 How Are Quarantine Impacting on the Health-Related Quality of Life?

    Sep 1, 2020, 00:00

  • PDG6 A Cost/Cost-Utility Analysis of Cefaclor Hypersensitivity in South Korea

    Sep 1, 2020, 00:00

  • PNS55 The Effect of Pharmaceutical Policy on Demand for Branded Medicines: A Discrete Choice Experiment from Australia

    Sep 1, 2020, 00:00

  • PIN35 Evaluation of Effectiveness of Knowledge Transfer of Antimicrobial Resistance to Hong Kong Elderly: A Quasi-Experiment

    Sep 1, 2020, 00:00

  • PDG7 Cost Minimization Analysis of Dexamethasone Intravitreal Implant and Ranibizumab for Rvo-Macular Edema in China

    Sep 1, 2020, 00:00

  • PIN32 Disease Burden of Hepatitis C Infection Among the General Population in ASIA: A Systematic Review

    Sep 1, 2020, 00:00

  • PCN18 A Budget IMPACT Analysis of Fixed Dose Combination of Netupitant and Palonosetron (NEPA) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Malaysia

    Sep 1, 2020, 00:00

  • PGI2 Quantitative Evaluation to Efficacy and Safety of Biosimilar of Infliximab in Inflammatory Bowel Diseases: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

    Sep 1, 2020, 00:00

  • PIH10 Estimating Economic Burden of CHILD Asthma Attributing to Exposure to PM2.5 in JAPAN

    Sep 1, 2020, 00:00

  • PNS21 Drug Pricing System Reform and the Formal Introduction of Health Technology Assessment in JAPAN

    Sep 1, 2020, 00:00

  • PCN8 Real World Treatment Patterns, Healthcare Resource Utilization (HCRU), Economic Outcomes and Survival Associated with Esophageal Cancer in JAPAN

    Sep 1, 2020, 00:00

  • PRS8 The Cost Effectiveness Analysis of SIX COPD Treatment Strategies in China

    Sep 1, 2020, 00:00

  • PRS18 The IMPACT of Idiopathic Pulmonary Fibrosis on Health State Utility Values: Evidence from Australia

    Sep 1, 2020, 00:00

  • PCV21 Association between Low-Income Status and Death in Japanese Patients with Heart Failure: Life Study

    Sep 1, 2020, 00:00

  • PSS4 Disease Burden of Rvo-ME in China – a Societal VALUE Perspective

    Sep 1, 2020, 00:00

  • Valuing Health State: An EQ-5D-5L Value Set for Ethiopians [Editor's Choice]

    Sep 1, 2020, 00:00

  • PDG21 Risk-Sharing Agreements: Experience That China Could Learn from European and Other EAST-Asian Countries

    Sep 1, 2020, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6 (current)
  • 7
  • 8
  • 9
  • 10
  • »